Why Is BAXTER INTL INC (BAX) Stock Up Today?

BAX stock is up 18.68% at $29.39 as of the latest data, driven by the company’s second-quarter 2026 earnings report and revised full-year guidance. The firm reported stronger-than-expected results across all business segments and cited a one-time tariff refund as a contributing factor. Baxter raised its full-year revenue and adjusted earnings per share guidance, citing strong demand for intravenous solutions and broader segment growth.

What Happened

Baxter International Inc. released its second-quarter 2026 results, with non-GAAP earnings per share of $0.56, exceeding estimates by $0.19. Revenue for the quarter reached $2.96 billion, surpassing expectations by $160 million. The company attributed the outperformance to robust demand for IV solutions and a favorable one-time tariff refund. As a result, Baxter increased its full-year 2026 guidance for both revenue and adjusted earnings per share. The SEC 8-K filing on July 30 confirmed the results and outlined the financial details. The stock opened with a 1.3% gap up and surged further to a session high of $30.00 shortly after the market opened.

What The Data Shows

The stock’s intraday trajectory showed significant momentum, with volume at 1.6 million shares, or 0.2 times the 3-month daily average. The price climbed from an open of $25.10 to a high of $30.00 within the first hour of trading. The stock remains within its 52-week range of $15.73 to $29.00, though it has exceeded the previous 52-week high. Recent congressional trades show four purchases and one sale of BAX shares over the last 90 days, with the most recent filing on July 1. No unusual options activity or significant short interest data was reported.

What To Watch

The next key event for BAX will be its scheduled earnings release for the third quarter of 2026. Investors should also monitor the breadth of analyst coverage, as recent upgrades from UBS, Stifel, and TD Cowen reflect a cautious but improving outlook.